focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
You are right... Patience and don't looking too often is good strategy to avoid day to day sp movements and feeling pressure. It's difficult but that's the way... My average is 16.45 with 2626 shares... I thought 2626 will be a fortune number but it did not work so far... But hope it will work one day.
Apparently, there are no risks... Just a perception that Pharmaceutical sector is not considering as a growth stock...? Is world will start living without medicines? Shorters part cannot down this much to stocks with small numbers... Initially thought Directors purchased over one million shares at a much higher price, now realized those are only less than 2% their holdings in Hikma and remaining number purchased in past at much lower cost, So in total, they still have multiple times of profit... need a strong turn from here.. I know trading statement due next month....
I trapped when start looking year low.. and start buying....Don't know where it stop.. when turn around. Why directors don't buy now? Its half the price from when they purchase less than year ago... Is it true that now more growth expecting for Hikma?.
Last year directors bought loads of shares...seems no one in the pharma world was expecting this downfall. My average down to 16.50 and my worry is that I keep buying and end up having 90% of portfolio only Hikma...Hope it will recover in a year time.